← FDA Drug Approvals (Drugs@FDA)

KALETRA

NDA · New Drug Application · Sponsor: ABBVIE · Approved 2000-09-15

Drug application

FDA Application #

NDA021226

Application type

New Drug Application

Brand name

KALETRA

Generic name

Lopinavir

Active ingredients

LOPINAVIR; RITONAVIR

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

ABBVIE

First approval

2000-09-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown